Kansas Sci-Tech Reporter
SEE OTHER BRANDS

Your science and technology news from Kansas

Kansas Sci-Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Sci-Tech Reporter.

Press releases published on September 11, 2025

EIN Presswire Unveils First Case Study on Using Press Releases to Increase AI Search Visibility and Media Coverage

EIN Presswire Unveils First Case Study on Using Press Releases to Increase AI Search Visibility and Media Coverage

How My Home Pathway leveraged EIN Presswire to expand reach, enhance AI search visibility, and build media momentum. WASHINGTON , DC, UNITED STATES, September 11, 2025 /⁨EINPresswire.com⁩/ -- It’s no secret that people are increasingly using artificial …

Garden City Unveils Kansas’ First Augmented Reality Mural, Blending Art, Technology, and Storytelling

Garden City Unveils Kansas’ First Augmented Reality Mural, Blending Art, Technology, and Storytelling

70-foot "Majestic Monarch Butterfly" augmented reality mural transforms downtown Garden City, Kansas, into an interactive cultural destination. GARDEN CITY, KS, UNITED STATES, September 11, 2025 /⁨EINPresswire.com⁩/ -- Garden City will make Kansas history …

 Geotab Surpasses 5 Million Global Connected Vehicle Subscriptions

Geotab Surpasses 5 Million Global Connected Vehicle Subscriptions

SYDNEY, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Geotab Inc. (“Geotab”), today announced it has achieved a new company milestone, surpassing 5 million connected vehicle subscriptions worldwide. This rapid growth, with the last million subscriptions added in less …

Correction: Next Technology Holding Inc. Announces Reverse Stock Split

Correction: Next Technology Holding Inc. Announces Reverse Stock Split

CHEYENNE, Wyoming, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Next Technology Holding Inc. (“NXTT” or the “Company”) (NASDAQ: NXTT), a technology firm committed to delivering AI-enabled software development services and strategic Bitcoin acquisition, announced …

ESET Shares CISO Perspectives and Priorities in MSP Summit Keynote

ESET Shares CISO Perspectives and Priorities in MSP Summit Keynote

SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today announced that its Field CISO Charles “Chuck” Everette will deliver a keynote “From the CISO’s Desk: Redefining MSP Partnerships in Today’s Threat Landscape” at the …

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of …

Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List

Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List

BASEL, Switzerland and LONDON and NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Great Place To Work® and Fortune magazine have selected Roivant (Nasdaq: ROIV) for the 2025 Fortune Best Workplaces in BioPharma™ List. This is Roivant’s first time being named …

San Antonio JCE SEO Digital Marketing Agency Nears 20 Years in Business

San Antonio JCE SEO Digital Marketing Agency Nears 20 Years in Business

JCE SEO Celebrates Nearly Two Decades of Digital Marketing Excellence in San Antonio Family-founded agency expands services in SEO, web design, and digital advertising while strengthening support for Texas businesses San Antonio, TX , Sept. 11, 2025 (GLOBE …

NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing

NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing

TORONTO and HAIFA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to …

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

NEW YORK and WALTHAM, Mass., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …

Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

BOSTON and SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …

Energous Announces Closing of Registered Direct Offering and Concurrent Warrant Exercise for $5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Energous Announces Closing of Registered Direct Offering and Concurrent Warrant Exercise for $5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

SAN JOSE, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Energous Corporation d/b/a Energous Wireless Power Solutions (Nasdaq: WATT) (“Energous” or the “Company”), a pioneer in scalable, over-the-air (OTA) wireless power networks, today announced the closing …

IBEX Reports Strongest Quarterly Growth Rate in Nearly 3 Years, Record Fiscal Year 2025 Financial Results, Introduces Fiscal Year 2026 Guidance

IBEX Reports Strongest Quarterly Growth Rate in Nearly 3 Years, Record Fiscal Year 2025 Financial Results, Introduces Fiscal Year 2026 Guidance

Record fourth quarter and full-year Revenue, EPS, Adjusted EPS, and Free Cash Flow Fourth quarter revenue grew 18.2% versus prior year quarter, and full-year revenue grew 9.8% Fourth quarter EPS of $0.66 and adjusted EPS of $0.87 grew 19% and 50%, …

Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …

Next Technology Holding Inc. Announces Reverse Stock Split

Next Technology Holding Inc. Announces Reverse Stock Split

CHEYENNE, Wyoming, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Next Technology Holding Inc. (“NXTT” or the “Company”) (NASDAQ: NXTT), a technology firm committed to delivering AI-enabled software development services and strategic Bitcoin acquisition, announced …

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Company announcement – No. 20 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 11, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a …

Alonaw Business School Celebrates Five-Year Milestone with Record Enrollment in AI-Enhanced Investment Course

Alonaw Business School Celebrates Five-Year Milestone with Record Enrollment in AI-Enhanced Investment Course

Denver, Colorado,, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Alonaw Business School commemorates five years of investment education excellence as its fifth annual course series achieves record-breaking enrollment, reflecting growing demand for AI-integrated …

Recludix Pharma to Present at the Stifel 2025 Virtual Immunology and Inflammation Forum

Recludix Pharma to Present at the Stifel 2025 Virtual Immunology and Inflammation Forum

SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer, Ajay Nirula, M.D., …

Lipomax Drops Official Launch 2025: Himalayan Pink Salt Trick Weight Management Formula Explained

Lipomax Drops Official Launch 2025: Himalayan Pink Salt Trick Weight Management Formula Explained

New York City, NY, Sept. 11, 2025 (GLOBE NEWSWIRE) -- An Independent, In-Depth Analysis “Lipomax Drops”? Lipomax Drops have officially launched in 2025, marking their entry into the liquid weight-management supplement category. This comprehensive guide …

Le fonds Sarat Ventures Y Innovations Biotech Fund prévoit d’investir dans des entreprises en phase de démarrage, plus particulièrement en Arabie saoudite et dans la région MENA

Le fonds Sarat Ventures Y Innovations Biotech Fund prévoit d’investir dans des entreprises en phase de démarrage, plus particulièrement en Arabie saoudite et dans la région MENA

LONDRES, 11 sept. 2025 (GLOBE NEWSWIRE) -- Dans le cadre d’une initiative historique visant à positionner l’Arabie saoudite comme un pôle mondial de la biotechnologie, le fonds Sarat Ventures Y Innovations Biotech Fund (Royaume-Uni) a annoncé aujourd’hui …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions